Mass distribution of azithromycin to prevent under-five mortality in sub-Saharan Africa: Do the benefits outweigh the costs with regard to antimicrobial resistance?

Abstract

Sub-Saharan Africa (sSA) accounts for the highest burden of under-five mortality (U5M) globally, with an estimated under-five mortality rate (U5MR) of 76 deaths per 1000 live births in 2018, leading to approximately 2.7 million deaths.1 The region alone accounts for over 55% of the global under-five deaths despite having less than 30% of the world’s under-five population.2.

Keywords

• azithromycin